Home > National Drug Code (NDC) > Methotrexate

Methotrexate - 61703-350-38 - (METHOTREXATE SODIUM)

Alphabetical Index


Drug Information of Methotrexate

Product NDC: 61703-350
Proprietary Name: Methotrexate
Non Proprietary Name: METHOTREXATE SODIUM
Active Ingredient(s): 25    mg/mL & nbsp;   METHOTREXATE SODIUM
Administration Route(s): INTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Methotrexate

Product NDC: 61703-350
Labeler Name: Hospira Worldwide, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA011719
Marketing Category: NDA
Start Marketing Date: 20041215

Package Information of Methotrexate

Package NDC: 61703-350-38
Package Description: 5 VIAL in 1 CARTON (61703-350-38) > 2 mL in 1 VIAL

NDC Information of Methotrexate

NDC Code 61703-350-38
Proprietary Name Methotrexate
Package Description 5 VIAL in 1 CARTON (61703-350-38) > 2 mL in 1 VIAL
Product NDC 61703-350
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name METHOTREXATE SODIUM
Dosage Form Name INJECTION, SOLUTION
Route Name INTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20041215
Marketing Category Name NDA
Labeler Name Hospira Worldwide, Inc.
Substance Name METHOTREXATE SODIUM
Strength Number 25
Strength Unit mg/mL
Pharmaceutical Classes Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]

Complete Information of Methotrexate


General Information